Material Agreement · Company Update

XOMA Royalty Corporation entered into a merger agreement with Ligand Pharmaceuticals Incorporated and Flex Merger Sub, Inc. on April 27, 2026, to be acquired by Ligand Pharmaceuticals Incorporated. The transaction includes a cash payment and contingent value rights for XOMA Royalty shareholders.